SCHEDULE 13D

Company

Pasithea Therapeutics Corp.

Filed

June 8, 2023

Accession Number

0001213900-23-047253

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →